Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Collaborative R&D project

13 Oct 2009 07:00

RNS Number : 6207A
Surface Transforms PLC
13 October 2009
 



Surface Transforms Plc

("Surface Transforms" or "the Company")

The commencement of £2.1 million Collaborative R&D Project

part funded by grants from the UK Technology Strategy Board ("TSB")

Surface Transforms is pleased to announce the start of a three year, £2.1 million collaborative research and development project. The Technology Strategy Board has agreed to fund the project with a grant of £1.12 million to a consortium of companies led by Surface Transforms.

The aim of this R&D project, with the acronym "Sμrface", is to develop an innovative ceramic diskusing both waste carbon and contemporary manufacturing processes. The objectives are improved friction characteristics and substantially reduced wear with the development of a method that will allow worn ceramic disks to be resurfaced for re-use.

Success in the Sμrface project will enable a much greater flexibility and tolerance in the structure of the core material used in the disc, which will impact directly on reducing cost and increasing performance.

The Company's partners in this collaborative project are:-

* Faiveley Transport Ltd (manufacturer of train braking systems)

* Alcon Components Ltd (brake systems for high performance cars)

* Bentley Motors Ltd (OEM high performance car manufacturer)

* Federal-Mogul Friction Products Ltd (brake pads)

Loughborough University (specifications, analysis, testing)

Surface Transforms is the lead company and project co-ordinator and will be supplying the proprietary technology relating to the manufacture of carbon ceramic brake discs. The other industrial partners are all technology leaders in their respective fields of innovative friction material technology for use in the transport market. 

The project commenced on 1st September 2009 with the contribution from the Technology Strategy Board grant to Surface Transforms estimated at £470,000 over the next three years.

Kevin D'Silva, Surface Transform's Chairman, commented: 

Kevin D'Silva, Surface Transform's Chairman, commented: "This is the second time that the company has been successful in accessing Technology Strategy Board investment finding. We are pleased that the Technology Strategy Board has approved the Company as co-ordinator for this project."

Enquiries:

 

Surface Transforms Plc
+44 (0) 151 356 2141
Kevin D'Silva
 
Kevin Johnson
 
 
 
Seymour Pierce Limited
+ 44 (0) 207 107 8000
Corporate Finance
 
Nandita Sahgal
 
Christopher Wren
 
 
 
Corporate Broking
 
Paul Jewell
 

 

 

Notes.

"The Technology Strategy Board is a business-led executive non-departmental public body, established by the government. Its role is to promote and support research into, and development and exploitation of, technology and innovation for the benefit of UK business, in order to increase economic growth and improve the quality of life. It is sponsored by the Department for Business, Innovation and Skills (BIS). For more information please visit www.innovateuk.org"

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFWFEESUSEIS
Date   Source Headline
1st May 20207:00 amRNSResult of over-subscribed open offer
24th Apr 20204:17 pmRNSHolding(s) in Company
23rd Apr 202011:35 amEQSHardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
21st Apr 20207:00 amRNSOpen Offer application form - update
20th Apr 202010:20 amRNSHolding(s) in Company
17th Apr 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
9th Apr 20203:00 pmRNSPlacing and Open Offer
27th Mar 20207:00 amRNSDeferral of Publication of Results &COVID19 Update
28th Feb 20207:00 amRNSUnaudited interims for the 6 m/e 30 November 2019
10th Feb 20208:27 amRNSHolding(s) in Company
28th Jan 20205:30 pmRNSAppointment of Sales Director and Grant of Options
27th Jan 20202:00 pmRNSDirector/PDMR Shareholding
10th Jan 20207:00 amRNSTrading and operational update
5th Dec 20197:00 amRNSGrant of options
13th Nov 20198:33 amRNSExercise of options
13th Nov 20198:27 amRNSResult of AGM
6th Nov 201910:01 amRNSHolding(s) in Company
6th Nov 20199:00 amRNSExercise of Options and PDMR Dealing
25th Oct 201912:56 pmEQSHardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects
17th Oct 20197:00 amRNSPosting of Annual Report and Notice of AGM
2nd Oct 201910:55 amRNSDirector/PDMR Shareholding
26th Sep 20197:00 amRNSContract award from OEM 1
19th Sep 20197:00 amRNSCapital Markets Day
18th Sep 201910:50 amRNSHolding(s) in Company
9th Sep 20197:00 amRNSPreliminary results and notice of AGM
5th Sep 20194:10 pmEQSHardman & Co Research: Surface Transforms (SCE): Rapid acceleration - 'game-change' announcements
27th Aug 20197:00 amRNSContract Agreement with German OEM 5
15th Aug 20197:00 amRNSChange of Financial Year End Date
16th Jul 20197:00 amRNSContract award from German OEM 5
28th Jun 20197:00 amRNSContract Awards and Commercial Settlement
16th May 20197:00 amRNSDirector/PDMR Shareholding
7th May 20199:05 amRNSSecond Price Monitoring Extn
7th May 20199:00 amRNSPrice Monitoring Extension
7th May 20197:00 amRNSTrading Update
28th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20195:05 pmRNSHolding(s) in Company
20th Mar 20197:00 amRNS£1.9 million placing
26th Feb 20197:00 amRNSInterim Results
11th Dec 20185:36 pmRNSResult of AGM
6th Dec 20187:00 amRNSExercise of Options and Director Dealing
5th Dec 20187:00 amRNSGrant of Options
4th Dec 20187:00 amRNSTrading & Operational Update
17th Sep 20187:00 amRNSPreliminary Results and Notice of AGM
10th Sep 20187:00 amRNSBoard appointment
4th Jul 20183:19 pmRNSGrant of options
3rd Jul 20187:00 amRNSHolding(s) in Company
27th Jun 20188:38 amRNS£1.5 Million Placing
13th Jun 20187:00 amRNSPre Close Trading, Customer and Operations Update
10th May 20187:00 amRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.